Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals.

Bibliographic Details
Title: Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals.
Authors: Tajiri, Kazuto, Okada, Kazuhiko, Ito, Hiroyuki, Kawai, Kengo, Kashii, Yoshiro, Tokimitsu, Yoshiharu, Muraishi, Nozomu, Murayama, Aiko, Hayashi, Yuka, Minemura, Masami, Takahara, Terumi, Shimizu, Yukihiro, Yasuda, Ichiro
Source: BMC Gastroenterology; 5/25/2023, Vol. 23 Issue 1, p1-8, 8p
Subject Terms: ANTIVIRAL agents, HEPATIC fibrosis, HEPATITIS C virus, THROMBOCYTOPENIA, LEUCOPENIA
Abstract: Background: Thrombocytopenia due to hypersplenism is a major complication of hepatitis C virus (HCV)-associated cirrhosis. HCV eradication improves these complications in some patients, but the long-term effects of HCV eradication on these complications remain unclear, especially in patients treated with direct acting antivirals (DAAs). The aim was to evaluate long term changes in thrombocytopenia and leucopenia after HCV eradication with DAAs. Methods: The present multicenter study retrospectively evaluated changes over 5 years in thrombocytopenia and leukocytopenia, as well as changes in liver fibrosis markers and spleen size, in 115 patients with HCV-cirrhosis treated with DAAs. Results: Thrombocytopenia and leukocytopenia were improved 4 weeks after DAA administration, with thrombocytopenia show further gradual improvement over the next year. Fib-4 index was markedly reduced 1 year after DAA, followed by subsequent gradual reduction over the next 4 years. Spleen size showed gradual annual reductions, with patients experiencing spleen size reduction characterized at baseline by bilirubinemia. Conclusions: Rapid DAA-associated HCV eradication might lead to rapid disappearance of liver inflammation and bone marrow suppression due to HCV infection. HCV eradication may gradually improve portal hypertension, reducing spleen size. [ABSTRACT FROM AUTHOR]
Copyright of BMC Gastroenterology is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Complementary Index
Full text is not displayed to guests.
More Details
ISSN:1471230X
DOI:10.1186/s12876-023-02829-w
Published in:BMC Gastroenterology
Language:English